Our Advisory Board
Dr. Ben-Zion Weiner
Dr. Weiner has been with Teva Pharmaceuticals since 1975. In January 2006, Dr. Weiner joined the Office of the CEO and assumed the role of Chief R&D Officer. Dr. Weiner served as Group Vice President - Global Products from April 2002 until January 2006. Previously, he served as Vice President - Research and Development from 1986 to 2002. He received a Ph.D. in chemistry from the Hebrew University, where he also earned B.Sc. and M.Sc. degrees. He conducted his post-doctorate research at Schering-Plough Corporation in the United States. He was granted the Rothschild Prize for Innovation/Export two times, in 1989 for the development of Alpha D3 for dialysis and osteoporosis patients and in 1999 for the development of Copaxone® for multiple sclerosis.
Prof. Avi Ohry
Prof. Avi Ohry, MD is an Expert in rehabilitation medicine, a Consultant to the Israeli Ministry of Health, the Israeli Ministry of Defense, the Israeli Ministry of Foreign Affairs and the Reuth Medical Center & Maccabi Sick Fund of Tel Aviv. Prof. Ohry served as Member of Biomedical Advisory Board at LifeWave Ltd. Prof. Ohry is a Director at the Israeli Spinal Cord Injury Rehabilitation Unit of Sheba Medical Center since 1985 and has been an Associate Professor of Rehabilitation Medicine at Tel Aviv University since 1998
